Obtaining three-dimensional cell cultures by ultrasound for in vitro studies
- Details
- Category: Technological offers
-
19 Feb 2024
A team from ITEFI CSIC has developed an ultrasound system that allows the generation of cellular clusters in the form of spheres for in vitro studies. It enables the straightforward creation of stable three-dimensional cell cultures in just a few minutes.
A platform to boost therapeutic modified oligonucleotides
- Details
- Category: Projects
-
12 Feb 2024
They are one of the most promising pharmacological tools, custom-designed for diseases such as Alzheimer's, various types of cancer, or multiple sclerosis. A multicenter project, with the participation of the CSIC, aims to create the XNA-HUB platform for designing new therapeutic molecules based on modified nucleic acids. For doing this, the platform will utilize supercomputing techniques and predictive models of Artificial Intelligence.
A biomaterial based on eggshell membrane for bone regeneration
- Details
- Category: Technological offers
-
30 Oct 2023
A multicentre study led by the CSIC has developed a biomaterial based on the eggshell membrane, which takes advantage of its natural qualities to obtain a biohybrid material with future applications in guided bone regeneration and pulp capping.
A new non-steroidal anti-inflammatory and immune regulator that can replace corticosteroids has been developed
- Details
- Category: Projects
-
12 Dec 2023
Created by a team led by the CSIC and the UPV, it is capable of inhibiting the cytokine storm associated with severe inflammation while preserving innate immunity. It is a synthetic derivative of andrographolide, the active ingredient of the plant Andrographis paniculate, commonly known as kalmegh or King of Bitters. It may also be useful in the treatment of rheumatoid arthritis, Crohn's disease, lung inflammation and fatty liver disease.
Scientists develop a device to quickly identify micro-organisms in an environmental sample
- Details
- Category: Projects
-
03 Aug 2023
The device, tested in Antarctica, optimises the efficient collection of samples and allows them to be analysed in situ. The breakthrough has been made possible by combining technologies that include the use of portable equipment to obtain and analyse DNA sequences, and proprietary analysis software, which has been patented. This development may also have applications in the clinical setting and in industry.